🇺🇸 FDA

Drug profile · INN

pertussis vaccine (recombinant, acellular, component, adsorbed)

VACPERTAGEN

EMA: approved J07AJ02
Patents linked
0
News articles
0

Quick answer

pertussis vaccine (recombinant, acellular, component, adsorbed) (VACPERTAGEN) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN pertussis vaccine (recombinant, acellular, component, adsorbed)
Brand VACPERTAGEN
ATC code J07AJ02

Frequently asked questions

What is pertussis vaccine (recombinant, acellular, component, adsorbed)?

pertussis vaccine (recombinant, acellular, component, adsorbed) (VACPERTAGEN) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for pertussis vaccine (recombinant, acellular, component, adsorbed)?

VACPERTAGEN is a marketed brand name for pertussis vaccine (recombinant, acellular, component, adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.